Back to Search Start Over

Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood

Authors :
Judith Zandstra
Annemarie van de Geer
Michael W. T. Tanck
Diana van Stijn-Bringas Dimitriades
Cathelijn E. M. Aarts
Sanne M. Dietz
Robin van Bruggen
Nina A. Schweintzger
Werner Zenz
Marieke Emonts
Dace Zavadska
Marko Pokorn
Effua Usuf
Henriette A. Moll
Luregn J. Schlapbach
Enitan D. Carrol
Stephane Paulus
Maria Tsolia
Colin Fink
Shunmay Yeung
Chisato Shimizu
Adriana Tremoulet
Rachel Galassini
Victoria J. Wright
Federico Martinón-Torres
Jethro Herberg
Jane Burns
Michael Levin
Taco W. Kuijpers
EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network
Graduate School
General Paediatrics
ACS - Pulmonary hypertension & thrombosis
AII - Infectious diseases
Epidemiology and Data Science
APH - Methodology
Landsteiner Laboratory
Paediatric Infectious Diseases / Rheumatology / Immunology
ARD - Amsterdam Reproduction and Development
University of Zurich
Zandstra, Judith
Pediatrics
Source :
Frontiers in Pediatrics, Frontiers in pediatrics, 8:355. Frontiers Media S.A., Frontiers in Pediatrics, 8:355. Frontiers Media S.A., Frontiers in Pediatrics, Vol 8 (2020)
Publication Year :
2020

Abstract

Background: Kawasaki disease (KD) is a vasculitis of early childhood mimicking several infectious diseases. Differentiation between KD and infectious diseases is essential as KD's most important complication—the development of coronary artery aneurysms (CAA)—can be largely avoided by timely treatment with intravenous immunoglobulins (IVIG). Currently, KD diagnosis is only based on clinical criteria. The aim of this study was to evaluate whether routine C-reactive protein (CRP) and additional inflammatory parameters myeloid-related protein 8/14 (MRP8/14 or S100A8/9) and human neutrophil-derived elastase (HNE) could distinguish KD from infectious diseases. Methods and Results: The cross-sectional study included KD patients and children with proven infections as well as febrile controls. Patients were recruited between July 2006 and December 2018 in Europe and USA. MRP8/14, CRP, and HNE were assessed for their discriminatory ability by multiple logistic regression analysis with backward selection and receiver operator characteristic (ROC) curves. In the discovery cohort, the combination of MRP8/14+CRP discriminated KD patients (n = 48) from patients with infection (n = 105), with area under the ROC curve (AUC) of 0.88. The HNE values did not improve discrimination. The first validation cohort confirmed the predictive value of MRP8/14+CRP to discriminate acute KD patients (n = 26) from those with infections (n = 150), with an AUC of 0.78. The second validation cohort of acute KD patients (n = 25) and febrile controls (n = 50) showed an AUC of 0.72, which improved to 0.84 when HNE was included. Conclusion: When used in combination, the plasma markers MRP8/14, CRP, and HNE may assist in the discrimination of KD from both proven and suspected infection.

Details

ISSN :
22962360
Database :
OpenAIRE
Journal :
Frontiers in Pediatrics
Accession number :
edsair.doi.dedup.....bd728ddee88693e89eaf15be34c0b61e
Full Text :
https://doi.org/10.3389/fped.2020.00355